A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: old-fashioned (3), old (260), square (21)

Durvalumab(28day-1500mg)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC - Durvalumab (28 day – 1500mg) Indication • Durvalumab is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf

ARIA - Blood Product questionnaires-prescribing-drug admin

Description
ARIA – Blood products – how to complete questionnaire, prescribe and add drug admin Prescriber – open patient, click Assessments – Questionnaires from drop down
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/ARIA-Blood-Product-questionnaires-prescribing-drug-admin.pdf

1607TalimogeneRx108PFU (2)

Description
TALIMOGENE 108PFU/ml for MELANOMA INITIAL PRESCRIPTION – Second and Subsequent ADMINISTRATIONS ONLY Please Attach Addressograph Patient Information Card Yes / No (please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx108PFU-2.pdf

1607TalimogeneRx106PFU (2)

Description
TALIMOGENE 106 PFU/ml for MELANOMA INITIAL PRESCRIPTION – FIRST ADMINISTRATION ONLY Please Attach Addressograph Patient Information Card Yes / No (please circle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx106PFU-2.pdf

Children's food challenge - patient information

Description
This factsheet includes what a food challenge is, what will happen during the challenge and how to care for your child
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Childrens-food-challenge-2424-PIL.pdf

Induction of labour - patient information

Description
Induction of labour Contents What is induction of labour? page 3 Reasons for induction page 3 If you are 12 days
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Induction-of-labour.pdf

Giving birth after a caesarean section - patient information

Description
We have written this factsheet to give you more information about the birth options available to you if you have had
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Giving-birth-after-a-caesarean-section.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituximab Venetoclax (high risk) Cycle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

Acalabrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treatment of chronic lymphocytic leukaemia (CLL) prior to EU
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf

Temozolomide (200)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (200) Regimen • CNS – Temozolomide (200) Indication • Recurrent or progressive malignant glioblastoma multiforme in patients not
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-200.pdf
351 to 360 of 1000
Previous … 34 35 36 37 38 … Next